DCF Advisers’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,000
Closed -$81K 67
2022
Q1
$81K Sell
1,000
-1,087
-52% -$88K 0.04% 56
2021
Q4
$423K Hold
2,087
0.17% 54
2021
Q3
$562K Hold
2,087
0.25% 55
2021
Q2
$537K Hold
2,087
0.19% 56
2021
Q1
$626K Hold
2,087
0.27% 55
2020
Q4
$532K Sell
2,087
-33
-2% -$8.41K 0.22% 56
2020
Q3
$528K Sell
2,120
-747
-26% -$186K 0.27% 50
2020
Q2
$996K Hold
2,867
0.56% 34
2020
Q1
$768K Hold
2,867
0.5% 33
2019
Q4
$928K Buy
+2,867
New +$928K 0.59% 28